Medpace Holdings, Inc. (MEDP)
419.91
-0.76
(-0.18%)
USD |
NASDAQ |
May 19, 16:00
420.12
+0.21
(+0.05%)
After-Hours: 20:00
Medpace Holdings EPS Diluted (Quarterly) : 4.277 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gossamer Bio, Inc. | -0.1993 |
| Thermo Fisher Scientific, Inc. | 4.426 |
| IQVIA Holdings, Inc. | 1.614 |
| Illumina, Inc. | 0.8701 |
| Revvity, Inc. | 0.364 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 123.87M |
| Revenue (Quarterly) | 706.60M |
| Total Expenses (Quarterly) | 582.73M |
| Enterprise Value | 11.49B |
| Gross Profit Margin (Quarterly) | 26.81% |
| Profit Margin (Quarterly) | 17.53% |
| Earnings Yield | 3.79% |
| Operating Earnings Yield | 4.63% |
| Normalized Earnings Yield | 3.786 |